Cutting Edge Spine

Cutting Edge Spine (CES) is a privately held orthopedic medical device manufacturer founded in 2009, headquartered in Waxhaw, North Carolina. The company specializes in developing and commercializing innovative spinal implant systems featuring proprietary bioactive materials and trabecular fixation technologies. CES holds three FDA-cleared product lines and an extensive patent portfolio for trabecular fixation across orthopedic applications. The company is recognized as the first to market in the U.S. with several bioactive spinal technologies, including hydroxyapatite (HA)-enhanced PEEK interbody systems designed to optimize osseointegration and early bone apposition. Core product offerings include lumbar interbody systems (EVOS-ha, EVOL-ha-C), lateral interbody fusion systems (EVOL-ha-DLIF), sacroiliac joint fusion systems (EVOL-SI), and specialized trabecular fixation screws. CES emphasizes clinical efficacy, quality assurance, and continuous R&D investment to deliver cost-effective solutions that improve patient outcomes while addressing healthcare provider economic concerns.